RKIP negatively regulates the glucose induced angiogenesis and endothelial-mesenchymal transition in retinal

Le Feng1, Conghui Zhang1, Guodong Liu1

  • 1Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Yanchang Road, Shanghai, 200072, China.

Experimental Eye Research
|October 27, 2019
PubMed

Insights

Raf kinase inhibitor protein (RKIP) negatively regulates diabetic retinopathy (DR) progression. Lower RKIP levels in the eye promote cell growth, migration, and blood vessel formation, contributing to DR development.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic retinopathy (DR) is a leading cause of blindness globally.
  • Reduced Raf kinase inhibitor protein (RKIP) levels are observed in proliferative diabetic retinopathy (PDR).
  • RKIP's role in PDR pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the functional role of RKIP in diabetic retinopathy.
  • To determine RKIP's effect on human retinal capillary endothelial cells (HRCECs) under high glucose conditions.
  • To elucidate RKIP's influence on cell viability, migration, angiogenesis, and endothelial-to-mesenchymal transition (EndMT).

Main Methods:

  • Stable RKIP overexpression (OE) and knockdown (KD) were established in HRCECs using lentivirus constructs.
  • Cells were exposed to high glucose conditions to mimic the diabetic environment.
  • Assays measured cell viability, migration, angiogenesis markers (CD31, vWF), and EndMT markers (α-SMA).

Main Results:

  • RKIP knockdown (KD) significantly increased glucose-induced HRCEC viability, migration, and angiogenesis.
  • RKIP overexpression (OE) significantly decreased glucose-induced HRCEC viability, migration, and angiogenesis.
  • RKIP KD upregulated CD31 and vWF while downregulating α-SMA; RKIP OE showed opposite effects under high glucose.

Conclusions:

  • RKIP acts as a negative regulator of glucose-induced cell viability, migration, angiogenesis, and EndMT in HRCECs.
  • The observed downregulation of RKIP in PDR patients may contribute to the development and progression of diabetic retinopathy.
  • Targeting RKIP could offer a potential therapeutic strategy for managing diabetic retinopathy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K